FDA Inspection 1103290 — New York Blood Center Inc
The FDA completed an inspection of New York Blood Center Inc on August 19, 2019 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 19, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)